BENGALURU: Gold extended declines to a four-month trough on Tuesday as investors dived into riskier assets following drugmaker AstraZeneca’s boost to the coronavirus vaccine race and a US federal agency’s White House transition approval for Joe Biden.
Spot gold fell 0.5% to US$1,825.99 per ounce by 0545 GMT, having earlier slid to its lowest since July 21 at US$1,820.45.
